Friday, August 9, 2013

Barclays Capital Increases Cognizant Technology Solutions Corp. Price Target ...

Barclays Capital Increases Cognizant Technology Solutions Corp. Price Target
Cognizant Technology Solutions Corp. logo Cognizant Technology Solutions Corp. (NASDAQ:CTSH) had its target price boosted by Barclays Capital from $ 70.00 to $ 80.00 in a report issued on Wednesday, StockRatingsNetwork reports. They currently have …
Read more

Aastrom Biosciences Inc (NASDAQ:ASTM) – A Leader in Tissue Repair Cell
Boston, MA, 08/08/2013 (nysepost) – Aastrom Biosciences Inc (NASDAQ:ASTM), a leader in the development of cell products for the repair and regeneration of human tissue is using an advanced Tissue Repair Cell (TRC) technology to treat chronic diseases.
Read more

Rubicon Technology's "Sell" Rating Reaffirmed at Goldman Sachs Group Inc
Rubicon Technology Inc. logo Rubicon Technology (NASDAQ:RBCN)'s stock had its "sell" rating reaffirmed by equities research analysts at Goldman Sachs Group Inc. in a research note issued to investors on Thursday, Analyst Ratings Network.com reports.
Read more

PLX TECHNOLOGY, INC. : Under AAAResearchReports.com Microscope: RF
The major movers in the sector included RF Micro Devices Inc. (NASDAQ: RFMD), Skyworks Solutions Inc. (NASDAQ: SWKS), Semtech Corp. (NASDAQ: SMTC), and PLX Technology Inc. (NASDAQ: PLXT). AAAResearchReports.com has released full …
Read more

Regen BioPharma Inc licenses cancer gene silencing technology, expanding its
Aug 09, 2013 (Menafn – M2 EQUITYBITES via COMTEX) –Biotechnology company Bio-Matrix Scientific Group Inc (otcqb:BMSN) said on Thursday that it has entered into a license agreement for the development of vaccines using ddRNAi gene silencing …
Read more


Related Post